This Transition Story Is a Growth Story
The company’s ability to execute its transition strategy gives this stock much more upside.
Matt Shuler, Investment Analyst II
Matt Shuler, Investment Analyst II
Unique Expertise and Secular Tailwinds Drive Profit Growth
This stock offers favorable risk/reward based on the company's strong customer relationships and industry expertise.
Matt Shuler, Investment Analyst II
Competitive Advantages Portend Continued Profit Growth
This stock offers investors significant long-term upside based on its strong sales team and extensive product offerings.
Matt Shuler, Investment Analyst II
Position Close Update: Zendesk (ZEN)
We’re closing this Danger Zone pick since there is little to stop the announced deal from going through.
Kyle Guske II, Senior Investment Analyst, MBA
Dividend Growth Stocks Model Portfolio: June 2022
Platinum Members and higher can access June's Dividend Growth Stocks Model Portfolio as of Wednesday, June 29.
Kyle Guske II, Senior Investment Analyst, MBA
Podcast: Why These Three Zombie Stocks Are in The Danger Zone
Investment Analyst Kyle Guske II sat down with Chuck Jaffe of Money Life to talk about our Danger Zone picks this week.
Kyle Guske II, Senior Investment Analyst, MBA
Position Close Update: Change Healthcare (CHNG)
We think now is the time to close this winning Long Idea.
Kyle Guske II, Senior Investment Analyst, MBA
Our Credit Ratings Picked for WealthManagement.com Industry Awards 2022
We are finalists in the “Industry Research Providers” category of WealthManagement.com’s 2022 Industry Awards.
Kyle Guske II, Senior Investment Analyst, MBA
New Feature: “Related Articles” Link on the Ratings Page
We’ve added a new “Related Articles” link to the Ratings pages of our site to make it easier to find our ad-hoc reports.
Kyle Guske II, Senior Investment Analyst, MBA
Three Stocks To Watch in a Wild Market – CNBC
We joined CNBC’s Power Lunch to discuss whether investors should buy or sell Altria (MO), Roku (ROKU), Kraft Heinz (KHC), and more.
Kyle Guske II, Senior Investment Analyst, MBA
Featured Stock in June’s Exec Comp & ROIC Model Portfolio
Get a free look at one of the stocks in this month's Model Portfolio.
Matt Shuler, Investment Analyst II
Zombie Stock #3 – Could Go to $0 As Fed Raises Rates
As the Fed raises interest rates and ends quantitative easing, access to cheap capital is drying up quickly.
Kyle Guske II, Senior Investment Analyst, MBA
Zombie Stock #2 – Could Go to $0 As Fed Raises Rates
These “zombie” companies are at risk of going bankrupt if they cannot raise more debt or equity, which is not as easy as it used to be.
Kyle Guske II, Senior Investment Analyst, MBA
Zombie Stock #1 – Could Go to $0 As Fed Raises Rates
Time is running out for cash-burning companies kept afloat with easy/cheap access to capital.
Kyle Guske II, Senior Investment Analyst, MBA
Safest Dividend Yields Model Portfolio: June 2022
Platinum Members and higher can access June's Safest Dividend Yields Model Portfolio as of Thursday, June 23.
Kyle Guske II, Senior Investment Analyst, MBA
Inflation Won’t Interrupt Cash Flows for This Business
This company’s ability to consistently adjust its tariffs means it is well positioned to deliver strong cash flows even in a high inflation environment.
Matt Shuler, Investment Analyst II
Biggest Valuation Disconnects in the S&P 500
40 companies, or just 8% of companies in the S&P 500, account for 50% of the Core Earnings for the entire S&P 500
Kyle Guske II, Senior Investment Analyst, MBA
ICYMI: An ETF with Big Upside, a Mutual Fund to Avoid, Sector & Industry Fundamentals Update, & Model Portfolio Updates
Here's what happened at New Constructs this past week.
Matt Shuler, Investment Analyst II
Big Upside in This Small Cap ETF
After rigorous analysis of ~1,000 ETFs, we identified another ETF with quality holdings at cheap valuations.
Matt Shuler, Investment Analyst II